Side effects of therapy of hepatitis C and their management

By M. Fried. Hepatology, 2002

719 citations recorded by the source corpus.

Subfields: Epidemiology, Hepatology

View Paper: https://www.semanticscholar.org/paper/2eaed8b1cfc22a264c1b88722b50a6c0a01bd95f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Christoph Sarrazin
2. A. Aghemo
3. G. Dusheiko
4. M. Puoti
5. X. Forns
6. J. Pawlotsky

In Hepatology

1. Christoph Sarrazin
2. A. Aghemo
3. G. Dusheiko
4. M. Puoti
5. X. Forns
6. J. Pawlotsky

Citations in the corpus

• EASL Recommendations on Treatment of Hepatitis C 2015. (2015, background): “Thyroxin and thyroid stimulating hormone (TSH) levels should be measured every 12 weeks while on therapy [60].”
• EASL Recommendations on Treatment of Hepatitis C 2018. (2018, background): “5 g/dl [39-47].”
• EASL Recommendations on Treatment of Hepatitis C 2016. (2017, background): “Thyroxin and thyroid stimulating hormone (TSH) levels should be measured every 12 weeks while on therapy [39].”